Maintenance of large numbers of virus-specific CD8+ T cells in HIV- infected progressors and long-term nonprogressors

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 1082-1092

  Gea Banacloche, Juan C ^a   Migueles, Stephen A ^a   Martino, Lisa ^a   Shupert, W Lesley ^a   McNeil, Andrew C ^a   Sabbaghian, M Shirin ^a   Ehler, Linda ^a   Prussin, Calman ^a   Stevens, Randy ^b   Lambert, Laurie ^b   Altman, John ^c   Hallahan, Claire W ^a   Lopez Bernaldo De Quiros, Juan Carlos ^d   Connors, Mark ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; GENE PRODUCT; POL PROTEIN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA;

EID: 0034661671     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.1082     Document Type: Article

References (74)

1. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991.
2. + lymphocytes. Science 283:857.
3. Matano, T., R. Shibata, C. Siemon, M. Connors, H. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164.
4. Gundlach, B. R., S. Reiprich, S. Sopper, R. E. Means, U. Dittmer, K. Matz-Rensing, C. Stahl-Hennig, and K. Uberla. 1998. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J. Virol. 72:7846.
5. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type I infection. N. Engl. J. Med. 332:201.
6. Cohen, O. J., A. Kinter, and A. S. Fauci. 1997. Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159:31.
7. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, S. I. Staprans, M. B. Feinberg, Y. Cao, D. D. Ho, T. Yilma, A. M. Caliendo, et al. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type I infection. AIDS Res. Hum. Retroviruses 12:585.
8. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
9. Pilgrim, A. K., G. Pantaleo, O. J. Cohen, L. M. Fink, J. Y. Zhou, J. T. Zhou, D. P. Bolognesi, A. S. Fauci, and D. C. Montefiori. 1997. Neutralizing antibody responses to human immunodeficiency virus type I in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176:924.
10. Rinaldo, C., X. L. Huang, Z. F. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, et al. 1995. High levels of anti-human immunodeficiency virus type I (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838.
11. + T cell responses associated with control of viremia. Science 278:1447.
12. + long-term survivor. AIDS Res. Hum. Retroviruses 10:1703.
13. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. [Published erratum appears in 1998 Science 280:1821.] Science 274:94.
14. + T cells during an acute virus infection. Immunity 8:167.
15. + T cells during the primary immune response to Epstein-Barr virus In vivo. J. Exp. Med. 187:1395.
16. + T cells in primary and secondary influenza pneumonia. Immunity 8:683.
17. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
18. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.
19. Lefrere, J. J., L. Morand-Joubert, M. Mariotti, H. Bludau, B. Burghoffer, J. C. Petit, and F. Roudot-Thoraval. 1997. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90:1133.
20. Vesanen, M., M. Markowitz, Y. Cao, D. D. Ho, and K. Saksela. 1997. Human immunodeficiency virus type-I mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells. Virology 236:104.
21. + lymphocyte activity. J. Infect. Dis. 172:329.
22. Lefrere, J. J., M. Mariotti, L. Morand-Joubert, M. Thauvin, and F. Roudot-Thoraval. 1999. Plasma human immunodeficiency virus RNA below 40 copies/ml is rare in untreated persons even in the first years of infection. J. Infect. Dis. 180:526.
23. + T cells and associated with a proliferative response to p24 antigen. J. Virol. 74:2023.
24. Migueles, S. A., M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola, D. Schwartz, J. Sullivan, and M. Connors. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 97:2709.
25. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355.
26. Cohen, O. J., S. Paolucci, S. M. Bende, M. Daucher, H. Moriuchi, M. Moriuchi, C. Cicala, R. T. Davey, Jr., B. Baird, and A. S. Fauci. 1998. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Δ32. J. Virol. 72:6215.
27. Walker, B. D. 1990. Techniques in HIV Research. Stocton Press, New York.
28. Holmes, K., B. Fowlkes, I. Schmid, and J. Giorgi. 1995. Preparation of cells and reagents for flow cytometry. In Current Protocols in Immunology, vol. 1. J. Coligan, A. Kruisbeek, D. Margulies, E. Sheevac, and W. Strober, eds. Green Publishing Associates, New York, p. 5.3.1.
29. Prussin, C., and D. D. Metcalfe. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anli-cytokine antibodies. J. Immunol. Methods 188:117.
30. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533.
31. Pannetier, C., J.-P. Levraud, A. Lim, J. Even, and P. Kourilsky. 1997. The immunoscope approach for the analysis of T-cell repertoires. In The Human Antigen T-Cell Receptor: Selected Protocols and Applications. J. Oksenberg, ed. R. G. Landes Company.
32. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.
33. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, and P. Kourilskky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807.
34. Genevee, C. A. Diu, J. Nierat, A. Caignard, P.-Y. Dietrich, L. Feradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
35. Choi, Y. W., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA 86:8941.
36. + T cell receptor repertoire. J. Infect. Dis. 177:579.
37. Kalams, S. A., S. P. Buchbinder, E. S. Rosenberg, J. M. Billingsley, D. S. Colbert, N. G. Jones, A. K. Shea, A. K. Trocha, and B. D. Walker. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type I infection. J. Virol. 73:6715.
38. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. J. Schrager, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209.
39. Strathdee, S. A., P. J. Veugelers, K. A. Page-Shafer, A. McNulty, A. R. Moss, M. T. Schechter, G. J. van Griensven, and R. A. Coutinho. 1996. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 10:959.
40. Dyer, W. B., G. S. Ogg, M. A. Demoitie, X. Jin, A. F. Geczy, S. L. Rowland-Jones, A. J. McMichael, D. F. Nixon, and J. S. Sullivan. 1999. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type I. J. Virol. 73:436.
41. + cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:273.
42. Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, P. Walden, and H. D. Volk. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4:975.
43. Silins, S. L., S. M. Cross, K. G. Krauer, D. J. Moss, C. W. Schmidt, and I. S. Misko. 1998. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J. Clin. Invest. 102:1551.
44. Larsson, M., X. Jin, B. Ramratnam, G. S. Ogg, J. Engelmayer, M. A. Demoitie, A. J. McMichael, W. I. Cox, R. M. Steinman, D. Nixon, and N. Bhardwaj. 1999. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13:767.
45. Selin, L. K., and R. M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J. Immunol. 158:5366.
46. + memory T cells. J. Exp. Med. 186:859.
47. Ogg, G. S., X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, et al. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:797.
48. + T cells. J. Exp. Med. 186:1407.
49. + T cell subsets in human T lymphotropic virus type I-infected individuals. J. Immunol. 161:6674.
50. Wilson, C. C., J. T. Wong, D. D. Girard, D. P. Merrill, M. Dynan, D. D. An, S. A. Kalams, R. P. Johnson, M. S. Hirsch, R. T. D'Aquila, et al. 1995. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type I-infected persons in the presence of combination antiretroviral agents. J. Infect. Dis. 172:88.
51. + T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94:9848.
52. + T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785.
53. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1780.
54. + responses in HIV type I-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108.
55. Grant, M. D., F. M. Smaill, D. P. Singal, and K. L. Rosenthal. 1992. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects. AIDS 6:1085.
56. Greenough, T. C., D. B. Brettler, M. Somasundaran, D. L. Panicali, and J. L. Sullivan. 1997. Human immunodeficiency virus type I-specific cytotoxic T lymphocytes (CTL). virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J. Infect. Dis. 176:118.
57. Bonfert, V., J. Cihak, U. Losch, and H. W. Ziegler-Heitbrock. 1995. Preferential expression of Vβ gene families in CD8 memory cells of apparently healthy donors. Cell. Immunol. 166:165.
58. + subset in normal human subjects. J. Immunol. 151: 5762.
59. Grunewald, J., M. Jeddi-Tehrani, H. Dersimonian, R. Andersson, and H. Wigzell. 1992. A persistent T cell expansion in the peripheral blood of a normal adult male: a new clinical entity? Clin. Exp. Immunol. 89:279.
60. Posnett, D. N., R. Sinha, S. Kabak, and C. Russo. 1994. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy." [Published erratum appears in 1994 J. Exp. Med. 179:1077.] J. Exp. Med. 179:609.
61. + T cell clones in elderly humans. J. Immunol. 158:4493.
62. + T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 154:3538.
63. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518.
64. Sourdive, D. J., K. Murali-Krishna, J. D. Altman, A. J. Zajac, J. K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Seite, and R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.
65. + subsets. Int. Immunol. 10:1281.
66. + population. Immunology 94:529.
67. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.
68. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205.
69. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, M. Roederer, and M. M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677.
70. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93:4102.
71. Wick, M., P. Dubey, H. Koeppen, C. T. Siegel, P. E. Fields, L. Chen, J. A. Bluestone, and H. Schreiber. 1997. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med. 186:229.
72. + cytolytic T lymphocytes. J. Exp. Med. 183:791.
73. + T cell-and IL-2-dependent mechanism. Immunity 11:483.
74. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301.